Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $104.50

U.S. Physical Therapy, Inc. (NYSE:USPH) has been given an average recommendation of “Moderate Buy” by the seven research firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $104.50.

Several research firms recently weighed in on USPH. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a research report on Friday, February 20th.

U.S. Physical Therapy Trading Down 1.3%

USPH opened at $74.22 on Friday. The stock’s fifty day moving average is $83.36 and its two-hundred day moving average is $81.97. The company has a market capitalization of $1.12 billion, a P/E ratio of 52.27, a PEG ratio of 1.90 and a beta of 1.30. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $93.50. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.32.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, February 26th. The company reported $0.67 earnings per share for the quarter, hitting the consensus estimate of $0.67. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The business had revenue of $202.73 million during the quarter, compared to analysts’ expectations of $200.10 million. During the same period in the prior year, the business earned $0.51 EPS. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. Analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Shareholders of record on Friday, March 13th will be issued a dividend of $0.46 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.45. This represents a $1.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Friday, March 13th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 129.58%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, EVP Richard Binstein sold 3,000 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $81.64, for a total transaction of $244,920.00. Following the sale, the executive vice president owned 24,867 shares of the company’s stock, valued at approximately $2,030,141.88. This trade represents a 10.77% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 662 shares of U.S. Physical Therapy stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total value of $52,205.32. Following the completion of the transaction, the chief operating officer owned 30,078 shares in the company, valued at $2,371,951.08. This represents a 2.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. raised its holdings in U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after purchasing an additional 132 shares in the last quarter. Advisory Services Network LLC bought a new stake in shares of U.S. Physical Therapy in the 3rd quarter valued at about $39,000. EverSource Wealth Advisors LLC boosted its holdings in shares of U.S. Physical Therapy by 68.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after buying an additional 192 shares in the last quarter. GAMMA Investing LLC grew its position in shares of U.S. Physical Therapy by 207.1% in the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after buying an additional 348 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $52,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.